Answers are grounded in this paper and cite their sources.
ddPCR of ctDNA may thus be an additional tool to discriminate pseudo-progression from true progression for tumors that harbor an oncogenic addiction.
No takes yet. Share an insight, caveat, or question.
Guibert et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: